Hepatocellular carcinoma in Australia 1982‐2014: Increasing incidence and improving survival
- 19 September 2018
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 39 (3) , 522-530
Abstract
Background & Aims: There is a paucity of accurate and current data on hepatocellular carcinoma (HCC) trends in incidence and survival in developed countries. We performed an Australia‐wide assessment of HCC epidemiology across a 33‐year time span aiming to accurately describe changes in incidence and survival.Methods: Cases of HCC from 1982 to 2014 were identified via the Australian Cancer Database (ACD). Trends in incidence rates were explored using piecewise linear regression. Survival was compared by Kaplan‐Meier survival curves and 1‐, 3‐ and 5‐year survival probabilities by year of diagnosis.Results: Age‐adjusted HCC incidence rate increased from 1.38 per 100 000 (95% CI: 1.34‐1.43) in 1982 to 4.96 per 100 000 (95% CI: 4.89‐5.03, P < 0.001) in 2014 with an average annual percentage increase of 4.46% (95% CI: 4.24%‐4.69%). The highest incidence rate in 2014 was in those aged 75‐79 (24.31 per 100 000; 95% CI: 19.50‐29.12). Almost 80% of cases across the period were men who had significantly higher age‐adjusted incidence rates in 2014 than women (8.55 per 100 000 [95% CI: 8.42‐8.68] vs 1.65 per 100 000 [95% CI: 1.60‐1.70]; P < 0.001). A hepatitis C (HCV) birth cohort effect was identified and associated with rapid increases in HCC incidence when members of the cohort aged and entered into age groups 45‐49, 50‐54 and 55‐59. Median survival increased from 2.10 months (95% CI: 1.57‐2.62 months) in those diagnosed between 1982 and 1984 to 12.07 months (95% CI: 11.17‐12.97 months) when diagnosed between 2010 and 2014 (P < 0.001).Conclusions: An Australia‐wide analysis of HCC epidemiological trends across three decades shows significant and consistent increases in both incidence and survival.Lay summary: There has been a significant increase in hepatocellular cancer (HCC) reported in Australia over the last three decades without evidence of slowing. Across the same time period, a significant improvement in survival has been identified with the average life expectancy after diagnosis now one year. This research lays the foundation for important public health service delivery.Keywords
This publication has 26 references indexed in Scilit:
- The evolving epidemiology of hepatocellular carcinoma: a global perspectiveExpert Review of Gastroenterology & Hepatology, 2015
- Temporal Trends of Nonalcoholic Fatty Liver Disease–Related Hepatocellular Carcinoma in the Veteran Affairs PopulationClinical Gastroenterology and Hepatology, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Emerging trends in hepatocellular carcinoma incidence and mortalityHepatology, 2014
- Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular CarcinomaGastroenterology, 2014
- Changing Hepatocellular Carcinoma Incidence and Liver Cancer Mortality Rates in the United StatesAmerican Journal of Gastroenterology, 2014
- Cancer statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based studyThe Lancet Oncology, 2014
- Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menaceJournal of Hepatology, 2012